• FBB August 2019 – Newsletter

    August 2019 – Newsletter
    The French BioBeach is thrilled to introduce you to our new member, active in France and North America, Oncodesign. This biopharmaceutical company and its innovative solutions evolve so quickly that you must stay up to date.
    Aside, you will get the usual details to register for our next FBB happy hour networking event and others coming meeting in San Diego.
    Company of the month
    Oncodesign – vector of innovation
    Founded nearly 25 years ago by Dr. Philippe Genne, the Company’s CEO and Chairman, Oncodesign is a biopharmaceutical company dedicated to precision medicine. Its main driver is to fill the innovation gap in the healthcare industry with its comprehensive technological platforms integrated in a translational drug discovery engine.
    Technological innovation lies at the heart of Oncodesign’s model – the Etiology, Discovery and Experimentation activities designed and implemented by Oncodesign contribute to a more effective approach to the phenomenon of innate and acquired resistance, more efficient treatments and a reduction in therapeutic failures.

    Working alongside prestigious big pharma and biotechs (nearly 800 over the last decades), Oncodesign orients with success the R&D of new therapeutic and diagnostic tools.
    Throughout our range of services combining state-of-the-art medicinal chemistry, pharmacology, bioanalysis, DMPK (in GPx environment), imaging and Artificial Intelligence, Oncodesign is the R&D partner for both routine or complex and strategic programs. Our long track record in oncology is also applied to various therapeutic areas inflammation, immunology, immuno-onco and infectious diseases.
    Oncodesign’s technology has already enabled the targeting of several promising molecules with substantial therapeutic potential, mainly in oncology.


    From France to North America 

    Oncodesign is based in Dijon, France, in the heart of the town’s university and hospital hub, and within the Paris-Saclay Bio-cluster. Oncodesign has also 2 subsidiaries in Canada and the USA.   

    Oncodesign has 232 talented employees in France and North America.  

    We are your partner for both routine or complex projects. Challenge us!

    We will be pleased to see you when around!

    Explore our large spectrum of offerings and news on Oncodesign.com


    For instant news, follow us on





    For more information, please contact us.

    Copyright© 2019 Oncodesign. All rights reserved.

    Happy Hour Networking Event
    bella vista social club & caffe
    bella vista
    August 9th
    from 5pm to 7pm (PST)
    Social Activity Networking Event
    The survey stay open for new comments and suggestions.

    Local News/Events
    This month will be another occasion to fully appreciate the summer with its dose of sun.
    In the meantime, we hope to see you at our events!

    Kevin Adam, Beatrice David Shevlin and Stephane Richard of the French BioBeach team


    Follow our events and share to your friends/colleagues


    Thank You to our SPONSORS
    Résultats de recherche d'images pour « Perkinelmer »



    Copyright © French BioBeach, All Rights Reserved.
    Business Platform, San Diego Area, California, United States
    Don't want this? Click here to unsubscribe.
  • 2017 Oct, Featured Member of the month: APS

    Contact Information:
    Scott Barnhill,
    Business Development Executive 
    American Preclinical Services, LLC
    8945 Evergreen Blvd.
    Minneapolis, MN 55433
    Main Phone:
    Direct Phone:
    Direct Fax:

    The APS Preclinical Program:
    Your Path to Success 
    Finding a reliable partner in the preclinical CRO space can be challenging. In the early stages of product development, having a partner you can trust and rely on is of paramount importance.
    Welcome to American Preclinical Services. APS is an AAALAC and ISO17025 accredited, USDA registered and GLP compliant preclinical center of excellence located in Minneapolis, MN.

    At APS, we have developed a comprehensive Powerful Preclinical Program to assist companies in meeting their R&D goals. The APS Preclinical Program includes regulatory, biocompatibility, interventional medical device, surgical medical device, analytical, physician training, bioskills, pathology, pharmacology, and toxicology services. With this breadth of services under one roof, APS can advance your programs in all aspects of your product’s preclinical requirements. APS is adept at tailoring a Preclinical Program to fit your goals, with you and your team having direct collaborative control over study conduct and reporting timelines.
    Over 150 employees strong, the staff at APS have the scientific and technical expertise to guide your team in today’s fast paced and ever changing regulatory environment.  Whether you are conducting pilot evaluations, feasibility testing, or GLP studies, you will have industry experts to rely on every step of the way.

  • 2015 Jun, Featured Member of the month: Amylgen

    latribune_2015-805x1024 Vanessa Villard, CEO and co-founder manages all operational and financial aspects of AmylgenWatch Vanessa’s video at the “prix national du jeune entrepreneur”. She received her PhD in Neurosciences from the University of Montpellier 2. The topic of thesis was « the determination of the antiamnesic and neuroprotective effect of Anavex compounds in a non transgenic model of Alzheimer’s disease ». See Vanessa’s publications
    In parallel to running her company, she is studying for an Executive MBA at Sup de Co Montpellier Business School. Finally, yesterday Vanessa received the  award 'sciences and technologies''
    Amylgen is a privately owned contract research organization (CRO) offering a unique combination of validated in vivo models and a full range of behavioral, biochemical and morphological testing allowing fast and predictive screening of the effects of drugs and nutraceuticals on brain health.
    Amylgen is at your service to provide quick POC for your product as a food supplement for brain health and helps you to substantiate the efficacy of your product by preclinical studies in rodent models. Amylgen brings you preclinical scientific data for your product on:
    – Brain aging preservation
    – Memory enhancement
    – Antidepressant /anti anxiety effect
    – Protection against Alzheimer’s disease
    Amylgen has access to regulatory and clinical partners to aid in the preparation of health claims for EFSA or FDA and the commercialization of your product.
    Visit them on the web at amylgen.fr
  • 2015 Jan, Featured Member of the month: JPAC

    J-Pac-Medical-Logo-high-resFor more than 30 years, J-Pac Medical has provided high quality, innovative contract manufacturing solutions for the medical device and diagnostic industry (surgical implants, Point-of-Care diagnostics), with a depth and breadth of expertise that includes prototyping, process development, packaging solutions, and custom manufacturing. 
    J-Pac Medical’s core capabilities include specialized Forming, Cutting and Assembly and innovative processing techniques.  By employing an integrated approach that incorporates effective manipulation of materials, custom tools, process development and high volume automation, J-Pac Medical offers market-ready solutions that are swift-to-commercialization, scalable, and cost-effective. 
    Contact information: Blake S. Perkins,Director Business Development
    J-Pac Medical | 25 Centre Road Somersworth, NH 03878
    (Mobile) 603-343-8380 | (Office) 603-692-9955 x110 | (Fax) 603-692-0909
    (Email) bperkins@j-pacmedical.com   Visit us on the web at j-pacmedical.com


  • 2014 Dec, Featured Member of the month: APS


    Founded in 2005, American Preclinical Services (APS) is a State of the Art, ISO 17025 accredited, AAALAC accredited, USDA registered, and GLP compliant Contract Research Organization (CRO) located in Minneapolis, MN.
    APS performs SO10993, USP <87>, USP <88>, JMHLW, and custom biocompatibility testing. Our large and small animal research services include interventional, surgical, toxicology, pharmacology, pain, cadaver and bioskills labs and model development. 
    We have one of the largest preclinical capacities in the world including three Siemens catheterization labs. In addition to our in-vivo and in-vitro research services we also offer comprehensive pathology services for the medical device, biotech, and pharmaceutical industries. We’ve tailored our processes, capacity, and customer service to keep up with today’s fast paced business cycles. APS will go from a quote to a ready to implement study design with your time lines in full focus.
    Scott Barnhill, AS, SRS, RLATG
    Scientist/Business Development Executive 


  • 2014 Nov, Featured Member of the month: Roowin


    Patrice Rool created Roowin in 1998 and became CEO. Very creative in chemistry, he is the inventor of Roowin’s patents.


    Roowin, a company specialized in high added value fine chemistry, can support you in your projects of creation,             implementation, optimization and scale-up of efficient synthesis-routes and analysis methods.


    Roowin’s team is at your service for any chemistry research projects you want to entrust to us. In November 2009,           Roowin employed 35 chemists. Our management team with a PhD/Grande Ecole rate of 100% is looking forward to     all challenges you might want to share with  us.

    To learn more about Roowin: http://www.roowin.com/

  • 2014 Oct, Featured Member of the month: Ennov

    download (3)

    Based in San Francisco, CA, Ennov makes the most cost effective, comprehensive, and user-friendly solutions for regulated content management.

    They are proud to serve over 500 customers with a total of 250,000 users, ranging from leading pharmaceutical companies to emerging biotechnology companies throughout the life sciences industry.

    With over 15 years of experience and active feedback from customers, the Ennov team has fine-turned an all-in-one platform for faster deployment to market and continuous quality assurance. With the added efficiency of Ennov’s applications, their customers can accomodate their growing workload without nedding additiona resources.

    To learn more about Ennov: http://www.ennov.com/us/

  • 2014 Summer, Featured Member of the month: Integrium Clinical Research


    Integrium Clinical Research specializes in the strategy, study design, and execution of Phase I-IV clinical trials, with an expertise in Proof of Concept trials.

    It has strong clinical trial experience in a range of therapeutic indications including cardiovascular, metabolic, renal, inflammatory, dermatology, regenerative, orphan, and wound healing drug development. Founded in 1998, Integrium has 100+ employees with CRO, PK Unit, and Research Clinic locations in California, New Jersey, and South Africa. It has access to 7,000+ patients within varying disease states and 2,500+ healthy volunteers. It has also CRO partners in Europe, Australia, and India. The PK Unit is equipped with the necessary tools to run your Phase I POC study and the unparalleled Patient Recruitment team will assure your patient enrollment success.

    Please contact Randa Wahid for more details: Randa.Wahid@integrium.com


  • 2014 May, Featured Member of the month: Paul Herzog

    Paul Herzog practices immigration law with a focus on high-tech companies, universities, research institutes and small businesses/start ups. He earned his J.D. from Tulane University Law School and is member of the American Immigration Lawyers Association (AILA) and the Los Angeles County Bar Association-Immigration Section. Paul has written articles about immigration law, as well as lectured on immigration at schools and conferences. He currently serves as co-chair of the AILA Southern California LAX Customs & Border Patrol Liaison Group.

  • 2014 Apr, Featured Member of the month: Odexxo

        Phuong Nguyen is the founder and President of Odexxo Inc., and the mind behind the design of the company’s patented         technology. Phuong joined the Life Science field in the early 2000s, after a decade of experience in investment banking in     Monaco. She held sales and marketing positions at Thermo, Acon Labs and Alfa Scientific, and was responsible for                 developing European distribution channels for in-vitro diagnostic products.

    Phuong graduated with a business degree from the Ecole Superieure de Commerce in Clermont-Ferrand, France and an           MBA from the University of San Diego. She is trilingual English-French-Vietnamese, and has a good knowledge of                 Italian and German.

    ODEXXO Inc. specializes in the design, development and marketing of proprietary disposable devices for in-
    vitro diagnostic applications.

    ODEXXO’s products enable simple and clean handling of multiplex immuno-chromatographic rapid tests, offering physicians and veterinarians a very convenient point-of-care and field diagnostic tool. Launched in 2010, the technology has since been widely used by global veterinary IVD and pharmaceutical companies.
    In partnership with BIO-X, a Belgian veterinary diagnostic manufacturer, ODEXXO is launching the first complete porcine rapid test panel for the simultaneous detection of 8 pathogens that cause digestive diseases.